IL15 and colorectal carcinoma: In another study, IL-15 was found to potentiate the effect of immune checkpoint blockade using combined anti-PD-L1 and anti-CTLA-4, thereby leading to prolonged survival in a metastatic murine CT26 CRC model (122).